Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06189378
Other study ID # 1249/2023
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 7, 2023
Est. completion date October 29, 2023

Study information

Verified date January 2024
Source Medical University of Vienna
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial randomizes patients with a neurovascular diagnosis to a type of blood pressure diary for secondary stroke prevention (conventional blood pressure diary or blood pressure diary including patient-provided images). Outcomes include adherence and patient-reported outcomes.


Description:

In this prospective trial, the investigators randomized persons with diagnoses of stroke or transitoric ischemic attack into two groups: (i) 10 patients received a personalized blood pressure diary with pictures of their choosing. (ii) 10 patients received a blood pressure diary without photographs. The investigators instructed participants in either group to document their blood pressure at home twice daily over twenty-eight days.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date October 29, 2023
Est. primary completion date October 29, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - diagnosis of TIA or stroke (ischemic or hemorrhagic) upon admission. Exclusion Criteria: - Modified Rankin Scale score of =4 at inclusion - Inability to provide informed consent - Pre-existing legal guardianship.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Inclusion of patient-provided pictures into blood pressure diaries
Patient-provided pictures with positive meaning were included into blood pressure diaries
Conventional blood pressure diary
Conventional blood pressure diary

Locations

Country Name City State
Austria Medical University of Vienna Vienna

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Other Exploratory endpoints Exploratory endpoints evolved around patients' perspectives on blood pressure diaries as assessed by an empirical survey (13 questions in each group) conceived for this study. Possible answers were Likert-type scales, yes/no or open commentaries. 28 days
Primary Adherence The primary endpoint was adherence to blood pressure diaries defined as the number of complete blood pressure measurements (maximum of two per day) divided by the maximum number of measures over the study period (28 days, resulting in a maximum total of 56 measurements). Complete entries were defined as diary entries stating date, time and systolic as well as diastolic blood pressure. 28 days
Secondary Blood pressure Mean raw values of systolic and diastolic blood pressure 28 days
Secondary Precision of documentation of blood pressure The proportion of documented values ending with "0" or "5" served to assess the extent of rounding (i.e. the precision of documentation) 28 days
Secondary Patient Global Impression of Change Scale The Patient Global Impression of Change Scale is a self-report rating scale of 1 item on a Likert scale (maximum 7, higher score is better) and 1 item on a scale from 0-10 (higher score is worse). It was applied to assess patient satisfaction. 28 days
Secondary 36-Item Short Form Health Survey The 36-Item Short Form Health Survey is a self-report survey of items on a Likert Scale in 8 domains. It is designed to assess quality of life. The maximum amount of points is 100. More points are better. 28 days
Secondary Hospital Anxiety and Depression Scale The Hospital Anxiety and Depression Scale is a self-report rating scale of 14 items on a Likert scale. It is designed to measure anxiety and depression (7 items for each subscale). The maximum amount of points in each subscale is 21. More points are worse. 28 days
See also
  Status Clinical Trial Phase
Recruiting NCT04888221 - Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement Phase 3
Recruiting NCT04865718 - Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
Recruiting NCT04568161 - Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses N/A
Not yet recruiting NCT04537611 - Deoxyhemoglobin Concentration Changes and Cerebral Perfusion Imaging N/A